Your browser doesn't support javascript.
loading
Exploring the advancements of Australian OPAT.
Lai, Tony; Thiele, Horst; Rogers, Benjamin A; Hillock, Nadine; Adhikari, Suman; McNamara, Alexander; Rawlins, Matthew.
Afiliação
  • Lai T; The University of Sydney School of Pharmacy, Bank Building - The University Of Sydney, 3 Parramatta Rd, Camperdown NSW 2050, Australia.
  • Thiele H; Hospital in the Home, Northern Sydney Local Health District, St Leonards, NSW, Australia.
  • Rogers BA; Monash University School of Clinical Sciences at Monash Health, Clayton, VIC, Australia.
  • Hillock N; Hospital in the Home program, Monash Health, Clayton, VIC, Australia.
  • Adhikari S; National Antimicrobial Utilisation Surveillance Program, South Australia Health, Adelaide, SA, Australia.
  • McNamara A; Department of Pharmacy, St George Hospital, Kogarah, NSW, Australia.
  • Rawlins M; School of Clinical Medicine, The University of New South Wales, Sydney, NSW, Australia.
Ther Adv Infect Dis ; 10: 20499361231199582, 2023.
Article em En | MEDLINE | ID: mdl-37745256
ABSTRACT
Outpatient parenteral antimicrobial therapy (OPAT) in Australia has evolved from modest beginnings to a well-established health service with proven benefits in patient outcomes. This is a comprehensive review of the current state of art Australian OPAT with vignettes of the types of OPAT models of care, antimicrobial prescribing and antimicrobial use. In addition, we highlight the similarities and differences between OPAT to other countries and describe Australian OPAT experiences with COVID-19 and paediatrics. Australian OPAT continues to advance with OPAT antifungals, novel treatment options and upcoming high-impact research.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article